Contract Development


Faster & Better

As your most qualified world’s leading CDMO partner, Samsung Biologics delivers your success to IND & BLA Faster & Better with maximum flexibility.
We promise the Best.

Your molecule’s journey with Samsung Biologics’ Faster & Better CDO service.

Cell line development begins by the insertion of your gene of interest into an expression vector. The transfected cell expresses your target antibodies and the antibodies are secreted from the cells.

A large number of cell pools are then screened and single cell clones are isolated based on high titre and product quality. At the end of this process, the top 5 research cell banks are ranked and one is moved into process development.

During upstream process development, basal and feed media are optimised to ensure cell stability In bioreactors, pH, dissolved oxygen, temperature and other parameters are continuously optimised for the cell’s growth and viability to maximise production of your target protein.

Your target protein can be isolated through chromatography steps such as affinity and ion-exchange resin in downstream process. Impurities and viruses can be removed through chromatography and filter steps

In parallel with process development, optimal analytical conditions are set for your protein through size-exclusion chromatography, ELISA and more. A full spectrum of methods will be developed to evaluate purity, impurities, content and identification.

Buffers, surfactants and excipients are screened and combined to generate a stable liquid or lyophilized formulation for your target protein.

With the completion of the development process, your molecule moves into clinical production. Finally, the molecule is filled into vials ready for clinical trial.

As your most qualified world’s leading CDO, CMO, CRO partner, Samsung Biologics delivers your success to IND & BLA Faster & Better with maximum flexibility. We promise the Best.

Why Samsung Biologics CDO?

  • Contract Development Timeline
    • From Gene to IND in 9 months (Cell Line Development → Process Development → cGMP Manufacturing → IND Filing)
    • Accelerated Timelines (high productivity and stability)
  • Advanced Technology
    • Proprietary Cell Line, S-CHOice®
    • Process Development Platform, S-Cellerate™
    • Expertise in development of various molecules
  • Excellent Quality
    • mAb titer of 11.6g/L, Bispecific titer of 4+g/L
    • Dedicated Project Management
    • Regulatory Filing Support
  • Tailored Support
    • Flexible CDO Service scope
    • Competitive & Variable Cost Structure
  • Seamless One-stop Service
    • Fully integrated development & manufacturing service
    • Global #1 manufacturing capacity



Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.


Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.



Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.

Copyright Samsung Biologics. All rights reserved